|
Jun 13
|
Insider Sale: EVP and Chief Legal Officer Karah Parschauer Sells Shares of Ultragenyx ...
|
|
Jun 12
|
Ultragenyx Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
|
|
Jun 12
|
Ultragenyx Announces Plans to File for Accelerated Approval of UX111 for the Treatment of Sanfilippo Syndrome Type A (MPS IIIA)
|
|
Jun 12
|
Ultragenyx (RARE) Posts New Data From Bone Disease Study
|
|
May 22
|
Ultragenyx Faces Lawsuit Over Alleged Unjust Use of Henrietta Lacks' Cells
|
|
May 7
|
Ultragenyx to Participate at Bank of America’s 2024 Healthcare Conference
|
|
May 4
|
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Q1 2024 Earnings Call Transcript
|
|
May 4
|
Here's What Analysts Are Forecasting For Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) After Its First-Quarter Results
|
|
May 3
|
Ultragenyx Pharmaceutical Inc (RARE) (Q1 2024) Earnings Call Transcript Highlights: Key ...
|
|
May 3
|
Ultragenyx (RARE) Q1 Loss Wider Than Expected, Revenues Rise Y/Y
|
|
May 2
|
Ultragenyx Pharmaceutical Inc (RARE) Q1 2024 Earnings: Misses EPS Estimates, Revenue Grows ...
|
|
May 2
|
Ultragenyx Reports First Quarter 2024 Financial Results and Corporate Update
|
|
Apr 30
|
Ultragenyx Issues 2023 Corporate Responsibility Report, Showcasing Commitment to Improving Equity and Access to Innovation in Rare Disease
|
|
Apr 30
|
Ultragenyx Announces Completion of Enrollment in Phase 3 Orbit and Cosmic Studies Evaluating Setrusumab (UX143) for the Treatment of Osteogenesis Imperfecta (OI)
|
|
Apr 25
|
Ultragenyx to Host Conference Call for First Quarter 2024 Financial Results and Corporate Update
|
|
Apr 16
|
Ultragenyx (RARE) Meets Efficacy Goal in Neuro Disease Study
|
|
Apr 15
|
Ultragenyx says Angelman therapy is working, but safety questions remain
|
|
Apr 15
|
Ultragenyx Announces Positive Interim Phase 1/2 Data in Patients with Angelman Syndrome After Treatment with GTX-102
|
|
Apr 12
|
Ultragenyx Announces Update to Conference Call Timing to Discuss New Data from GTX-102 in Patients with Angelman Syndrome
|
|
Apr 12
|
Ultragenyx Announces Upcoming Data Presentations at American Academy of Neurology (AAN) 2024 Annual Meeting
|